Home Cart Sign in  
Chemical Structure| 1259224-00-4 Chemical Structure| 1259224-00-4

Structure of 1259224-00-4

Chemical Structure| 1259224-00-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1259224-00-4 ]

CAS No. :1259224-00-4
Formula : C15H22N2O2
M.W : 262.35
SMILES Code : O=C(OC(C)(C)C)NC1(C2=CC=C(N)C=C2)CCC1
MDL No. :MFCD18762015
InChI Key :SOYSJYBVYFILEK-UHFFFAOYSA-N
Pubchem ID :56924485

Safety of [ 1259224-00-4 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1259224-00-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 19
Num. arom. heavy atoms 6
Fraction Csp3 0.53
Num. rotatable bonds 5
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 76.55
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

64.35 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.54
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.44
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.07
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.2
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.26
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.5

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.91
Solubility 0.325 mg/ml ; 0.00124 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.43
Solubility 0.0965 mg/ml ; 0.000368 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.09
Solubility 0.0213 mg/ml ; 0.0000813 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.17 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.08

Application In Synthesis of [ 1259224-00-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1259224-00-4 ]

[ 1259224-00-4 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1259224-00-4 ]
  • [ 63558-65-6 ]
  • [ 1439396-79-8 ]
YieldReaction ConditionsOperation in experiment
59% With N-ethyl-N,N-diisopropylamine; In 1,4-dioxane; at 100℃; for 18h;Inert atmosphere; To a solution of 4-Chloro-5-iodo-pyrimidine (200 mg, 0.83 mmol) and [1- (4-Amino-phenyl)-cyclobutyl]-carbamic acid tert-butyl ester (218 mg, 0.83 mmol) in dioxane (10 mL) was added DIPEA (214 mg, 1.66 mmol). The mixture was heated at 100C for 18 h. After removal of solvent by concentration, the residue was purified by silica gel chromatography eluted with Hexane Ethyl acetate = 10:1 to give { l-[4-(5-Iodo-pyrimidin-4-ylamino)-phenyl]-cyclobutyl}- carbamic acid tert-butyl ester. (230 mg, 59%yield). LCMS (ESI+): 466.8 [M+l]+
  • 2
  • [ 1137576-38-5 ]
  • [ 1259224-00-4 ]
  • [ 1439395-38-6 ]
YieldReaction ConditionsOperation in experiment
50% With triethylamine; In 1,4-dioxane; at 80℃;Inert atmosphere; To the solution of <strong>[1137576-38-5]4,6-dichloro-5-iodopyrimidine</strong> (5.50 g, 20.00 mmol) (prepared according to the ref of Organic Letters; English; 11; 8; 2009; 1837 - 1840; ) in dioxane (100 mL) was slowly added the solution of tert-butyl l-(4-aminophenyl)cyclobutylcarbamate (5.2 g, 20.00 mmol) in dioxane (20 mL) and Et3N(5 ml). The reaction mixture was stirred at 80C for overnight, lc-ms indicated <strong>[1137576-38-5]4,6-dichloro-5-iodopyrimidine</strong> was completed consumed. After removed the excess solvents under the reduced pressure to get a residue, which was dissolved in Ethyl acetate (250 mL) and washed water and brine. The combined organic layer was dried over Na2S04 and then filtered, the filtrate was concentrated to give the crude product, which was further purified by flash chromatography to afford tert-butyl l-(4-(6-chloro-5-iodopyrimidin-4- ylamino)phenyl)cyclobutylcarbamate. (5.00 g 50% yield).LC/MS: (ESI+): 501 [M+l], 523 [M+Na].
  • 3
  • [ 1259224-00-4 ]
  • [ 187242-88-2 ]
  • [ 1439394-28-1 ]
YieldReaction ConditionsOperation in experiment
86% With sodium carbonate; In N,N-dimethyl acetamide; at 100℃; for 18.5h; 1? (48.0 g, 1.0 equiv.), 2? (59.0 g, 1.1 equiv.), and Na2CO3 (43.4 g, 2.0 equiv.) were charged to a 2 L, 3-neck flask. DMA (310 mL, 6.5 vol.) was added and the reaction was heated to 100 C. After 18.5 hours, HPLC analysis showed the reaction to be complete. The reaction was cooled to 9 C. and 2-MeTHF (960 mL, 20 vol.) was added. 10% aqueous solution of NaCl (720 mL, 15 vol.) was added resulting in some solid formation. The mixture was stirred for one hour and then transferred to a separatory funnel (rinsed the solids forward with 100 mL water). The layers were separated and the aqueous layer (Vaq1200 mL) was back extracted with 2-MeTHF (2×200 mL). The combined organics were then washed with 10% aqueous solution of NaCl (2×250 mL) and then analyzed by 1H NMR for DMA (0.3 wt %). After holding the solution overnight, an aliquot was taken out (6 mL) and was washed (3 mL) with water which resulted in a nice phase split (took >30 minutes). Water (650 mL, batch size) was added and stirred for 10 minutes and then transferred to a separatory funnel and allowed to sit. After 90 minutes, a partial phase split was realized (Vaq=250 mL). Brine (250 mL) was added resulting in a phase split. The organic layer (1300 mL, 27 vol., Kf=3.45%) was split off and charged to a 3-L RB flask. The flask was heated (atmospheric) to distill off some of the 2-MeTHF. Once 15 volumes of 2-MeTHF (720 mL) remained (30 minutes), the solution was reanalyzed for water content (Kf=0.24%). The reaction was then cooled to 50-55 C. and polished filtered through filter paper (very little solids present). The solution was then recharged to the 3-L flask (after cleaning flask) and the solution was distilled down to 9 volumes (430 mL). The solution was then heated to 70 C. and heptane was added in portions over one hour. The heat was then turned off and the solution was allowed to slowly cool to room temperature (after one hour the temperature was 48 C.). After stirring for 70 hours, the mother liquor was checked by HPLC analysis for 3 (2.7 mg/mL) and then filtered. The solids were washed with a 25% 2-MeTHF/heptane solution (75 mL, slurry) followed by 2×240 mL displacement wash with the same solution. The cake was washed one more time with heptane (240 mL) and then dried in a vacuum oven for 20 hours at room temperature. 3 (81.1 g, 86% yield, 99.2% AUC) was isolated as a dark red solid. 1H NMR (CDCl3) analysis showed no residual solvent present.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1259224-00-4 ]

Aryls

Chemical Structure| 180081-10-1

A166008 [180081-10-1]

tert-Butyl (2-(4-aminophenyl)-2-methylpropyl)carbamate

Similarity: 0.86

Chemical Structure| 94838-59-2

A113213 [94838-59-2]

tert-Butyl 4-aminophenethylcarbamate

Similarity: 0.86

Chemical Structure| 180079-94-1

A555592 [180079-94-1]

tert-Butyl 3-aminophenethylcarbamate

Similarity: 0.85

Chemical Structure| 170011-57-1

A249692 [170011-57-1]

tert-Butyl 4-(4-aminophenyl)piperidine-1-carboxylate

Similarity: 0.83

Chemical Structure| 94838-55-8

A234590 [94838-55-8]

4-(N-Boc-Aminomethyl)aniline

Similarity: 0.83

Amides

Chemical Structure| 180081-10-1

A166008 [180081-10-1]

tert-Butyl (2-(4-aminophenyl)-2-methylpropyl)carbamate

Similarity: 0.86

Chemical Structure| 94838-59-2

A113213 [94838-59-2]

tert-Butyl 4-aminophenethylcarbamate

Similarity: 0.86

Chemical Structure| 180079-94-1

A555592 [180079-94-1]

tert-Butyl 3-aminophenethylcarbamate

Similarity: 0.85

Chemical Structure| 170011-57-1

A249692 [170011-57-1]

tert-Butyl 4-(4-aminophenyl)piperidine-1-carboxylate

Similarity: 0.83

Chemical Structure| 94838-55-8

A234590 [94838-55-8]

4-(N-Boc-Aminomethyl)aniline

Similarity: 0.83

Amines

Chemical Structure| 180081-10-1

A166008 [180081-10-1]

tert-Butyl (2-(4-aminophenyl)-2-methylpropyl)carbamate

Similarity: 0.86

Chemical Structure| 94838-59-2

A113213 [94838-59-2]

tert-Butyl 4-aminophenethylcarbamate

Similarity: 0.86

Chemical Structure| 180079-94-1

A555592 [180079-94-1]

tert-Butyl 3-aminophenethylcarbamate

Similarity: 0.85

Chemical Structure| 170011-57-1

A249692 [170011-57-1]

tert-Butyl 4-(4-aminophenyl)piperidine-1-carboxylate

Similarity: 0.83

Chemical Structure| 94838-55-8

A234590 [94838-55-8]

4-(N-Boc-Aminomethyl)aniline

Similarity: 0.83